AMLX
Companies
NASDAQ
Amylyx Pharmaceuticals Inc.
Health Care
$5.03
+$1.25 (+32.94%)
Price Chart
Overview
About AMLX
Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.
Market Cap
$120.4M
Volume
5.3M
Avg. Volume
4.6M
P/E Ratio
-2.7324324
Dividend Yield
0.00%
Employees
321.0
Company Information
Latest News for AMLX
Why Is Small Cap Amylyx Pharmaceuticals Stock Trading Higher On Wednesday?
July 10, 2024
Final Trades: IBM, Exxon Mobil, Amylyx, and Home Depot
May 12, 2023
Stocks moving after hours: Twitter, Amylyx Pharmaceuticals, AutoZone, Airbnb
November 10, 2022
Wall Street Analysts See a 105.22% Upside in Amylyx Pharmaceuticals (AMLX): Can the Stock Really Move This High?
May 20, 2025
Risk & Correlation Analysis
Market Correlation
0.88
Moderate Correlation
Volatility
High (0.88)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, AMLX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$120.4M
Volume5.3M
P/E Ratio-2.73
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025